...
首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
【24h】

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.

机译:慢性阻塞性肺疾病患者支气管中血管内皮生长因子和受体(Flk-1和Flt-1)的表达增强。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Ongoing inflammatory processes resulting in airway and vascular remodelling characterise chronic obstructive pulmonary disease (COPD). Vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) could play a role in tissue remodelling and angiogenesis in COPD. METHODS: The cellular expression pattern of VEGF, Flt-1, and KDR/Flk-1 was examined by immunohistochemistry in central and peripheral lung tissues obtained from ex-smokers with COPD (forced expiratory volume in 1 second (FEV(1)) <75% predicted; n = 14) or without COPD (FEV(1) >85% predicted; n = 14). The immunohistochemical staining of each molecule was quantified using a visual scoring method with grades ranging from 0 (no) to 3 (intense). RESULTS: VEGF, Flt-1, and KDR/Flk-1 immunostaining was localised in vascular and airway smooth muscle (VSM and ASM) cells, bronchial, bronchiolar and alveolar epithelium, and macrophages. Pulmonary endothelial cells expressed Flt-1 and KDR/Flk-1 abundantly but not VEGF. Bronchial VEGF expression was higher in microvascular VSM cells and ASM cells of patients with COPD than in patients without COPD (1.7 and 1.6-fold, p<0.01, respectively). VEGF expression in intimal and medial VSM (1.7 and 1.3-fold, p<0.05) of peripheral pulmonary arteries associated with the bronchiolar airways was more intense in COPD, as was VEGF expression in the small pulmonary vessels in the alveolar region (1.5 and 1.7-fold, p<0.02). In patients with COPD, KDR/Flk-1 expression was enhanced in endothelial cells and in intimal and medial VSM (1.3, 1.9 and 1.5-fold, p<0.02) while endothelial Flt-1 expression was 1.7 times higher (p<0.03). VEGF expression was significantly increased in bronchiolar and alveolar epithelium as well as in bronchiolar macrophages (1.5-fold, p<0.001). The expression of VEGF in bronchial VSM and mucosal microvessels as well as bronchiolar epithelium was inversely correlated with FEV(1) (r<-0.45; p<0.01). CONCLUSIONS: VEGF and its receptors Flt-1 and KDR/Flk-1 may beinvolved in peripheral vascular and airway remodelling processes in an autocrine and/or paracrine manner. This system may also be associated with epithelial cell viability during airway wall remodelling in COPD.
机译:背景:正在进行的导致气道和血管重塑的炎症过程是慢性阻塞性肺疾病(COPD)的特征。血管内皮生长因子(VEGF)及其受体VEGFR-1(Flt-1)和VEGFR-2(KDR / Flk-1)可能在COPD的组织重塑和血管生成中发挥作用。方法:采用免疫组织化学方法检测COPD前吸烟者在1秒内的呼气量(FEV(1)) FEV(1)<预计75%; n = 14)或没有COPD(FEV(1)> 85%预测; n = 14)。使用视觉评分方法对每个分子的免疫组织化学染色进行定量,等级范围为0(否)至3(强烈)。结果:VEGF,Flt-1和KDR / Flk-1免疫染色定位于血管和气道平滑肌(VSM和ASM)细胞,支气管,支气管和肺泡上皮以及巨噬细胞中。肺内皮细胞大量表达Flt-1和KDR / Flk-1,但不表达VEGF。 COPD患者的微血管VSM细胞和ASM细胞中支气管VEGF的表达高于无COPD的患者(分别为1.7和1.6倍,p <0.01)。在COPD中,与细支气管气道相关的周围肺动脉内膜和内侧VSM中的VEGF表达(1.7和1.3倍,p <0.05)在肺泡中更为强烈,在肺泡区域的小肺血管中VEGF表达也是如此(1.5和1.7 -倍,p <0.02)。在患有COPD的患者中,内皮细胞,内膜和内侧VSM中KDR / Flk-1表达增强(1.3、1.9和1.5倍,p <0.02),而内皮Flt-1表达高1.7倍(p <0.03) 。 VEGF表达在细支气管和肺泡上皮以及细支气管巨噬细胞中显着增加(1.5倍,p <0.001)。 VEGF在支气管VSM和黏膜微血管以及支气管上皮中的表达与FEV(1)呈负相关(r <-0.45; p <0.01)。结论:VEGF及其受体Flt-1和KDR / Flk-1可能以自分泌和/或旁分泌方式参与外周血管和气道重塑过程。该系统也可能与COPD气道壁重塑过程中的上皮细胞活力有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号